Jones Financial Companies
RDY icon

Jones Financial Companies’s Dr. Reddy's Laboratories RDY Stock Holding History

Jones Financial Companies’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51
Closed -$716 – 4880
2025
Q4 		$716 Sell
51
-1,544
-97% -$21.7K ﹤0.01% 4094
2025
Q3 		$22.7K Buy
1,595
+1,413
+776% +$20.3K ﹤0.01% 2732
2025
Q2 		$2.74K Sell
182
-318
-64% -$4.54K ﹤0.01% 3360
2025
Q1 		$6.6K Buy
+500
New +$6.9K ﹤0.01% 2859
2024
Q3 		– Sell
-105
Closed -$1.6K – 3106
2024
Q2 		$1.6K Buy
+105
New +$1.5K ﹤0.01% 2207

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jones Financial Companies's RDY Position: Q1 2026 in Review

Jones Financial Companies sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 51 shares — an estimated $716 sold.

Jones Financial Companies first reported a position in RDY in Q2 2024 and held it in 5 quarters. The position peaked at $22.7K in Q3 2025. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Jones Financial Companies reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Jones Financial Companies sold 51 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $716.
  • Jones Financial Companies first reported a position in Dr. Reddy's Laboratories in Q2 2024 and held it in 5 quarters.
  • Jones Financial Companies's Dr. Reddy's Laboratories position peaked at $22.7K in Q3 2025.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.